Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02278003 · ClinicalTrials.gov registry record · NA
A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT02278003: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02278003 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02278003, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
The goal of this study is to extend findings of propofol's effects on memory, as measured in volunteer research studies, to a clinical setting.
Interventions
- DRUG Propofol
- OTHER memory test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2012-02 |
| Est. Completion | 2017-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02278003
The ClinicalTrials.gov registry entry for NCT02278003 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Propofol is the first listed.
NCT02278003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02278003 about?
NCT02278003 is a clinical study titled "A Pilot Study to Assess the Amnesic Properties of Propofol in Pediatric Patients". The goal of this study is to extend findings of propofol's effects on memory, as measured in volunteer research studies, to a clinical setting.
What is the current status of trial NCT02278003?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2012-02. Estimated completion is 2017-05-10.
What interventions are being tested in trial NCT02278003?
The interventions under investigation include: Propofol (DRUG), memory test (OTHER).
Who is sponsoring clinical trial NCT02278003?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.